ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP

NCT01971684 · clinicaltrials.gov ↗

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Immune Thrombocytopenia

Interventions

DRUG: Second Line ITP agents

Sponsor

Boston Children's Hospital

Collaborators

[object Object]